Literature DB >> 23741683

Herpes zoster in pregnancy leading to keloids and post herpetic neuralgia: A double whammy?

Shyam B Verma1, Uwe Wollina.   

Abstract

Entities:  

Year:  2013        PMID: 23741683      PMCID: PMC3673390          DOI: 10.4103/2229-5178.110646

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


× No keyword cloud information.
Sir, A 28-year-old woman came to the clinic with healed herpes zoster (HZ) scars in the T5, T6 dermatome and persistent pain in that area since the episode [Figure 1]. She developed HZ last year when she was 28 weeks pregnant. Her dermatologist advised her against any oral antivirals. Her HIV status was negative and still is. About 4 weeks later, she noticed her scars becoming prominent and gradually starting to showing keloidal features. From her history, she had a typical episode of HZ. She did not develop deep, necrotic lesions or have a secondary infection. She had a normal delivery and the child is in good health. She had no history or signs of scars or keloids and had a negative family history. She said that her keloids were itchy and painful sporadically. She also had post-herpetic neuralgia. The pain was lancinating in nature, sporadic, prominent in some positions, present between the keloids and around them in the entire dermatome. It did not respond adequately to NSAIDs, 1200 mg of gabapentin, which made her dizzy and somnolent, and 150 mg of pregabalin. She has been treated with intralesional triamcinolone acetonide 40 mg/ml and oral antihistamines for the itching. We await her response upon follow-up after one month.
Figure 1

Keloids in T5, T6 dermatome

Keloids in T5, T6 dermatome Keloids are benign connective tissue tumors developing due to an aberration in the normal wound-healing process. Darker skin types have a higher risk of keloid formation. Several cytokines and hormones are involved in keloid pathogenesis such as epidermal growth factor and tumor growth factor beta 1. Both are negatively correlated to scar formation. Melanocortin-1 receptor and alpha-melanocyte-stimulating hormone, activin-A, and follistatin are overexpressed in keloids and hypertrophic scars.[1-3] Both activin-A and follistatin are involved in the establishment and maintenance of pregnancy and are expressed and secreted by stromal endometrial cells.[4] Keloids developing in healing herpes zoster have been reported from India in an HIV positive woman.[5] A host of other sequelae have been described including erythema multiformae and segmental leukocytoclastic vasculitis, the latter two by the co-author.[6-8] In our case, HZ was responsible for local trauma leading to keloids. We hypothesize that pregnancy with increased expression of keloidal activin-A/follistatin and dark skin type are cofactors for the development of post-herpetic keloids. An association of pregnancy and HZ eventuating in keloid formation has never been reported in dermatological literature to the best of our knowledge. Oral antivirals administered during the episode probably would have prevented post-herpetic neuralgia (PHN) to some extent and this was made worse in our patient by the pain and itching of keloids.[9]
  9 in total

1.  The role of the activin system in keloid pathogenesis.

Authors:  Anandaroop Mukhopadhyay; Sui Yung Chan; Ivor J Lim; David J Phillips; Thang T Phan
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-13       Impact factor: 4.249

2.  Herpes zoster - associated erythema multiforme.

Authors:  Uwe Wollina; Astrid Gemmeke
Journal:  J Dermatol Case Rep       Date:  2009-04-05

3.  Segmental leukocytoclastic vasculitis in herpes zoster.

Authors:  Uwe Wollina; Jaqueline Schönlebe
Journal:  Int J Dermatol       Date:  2012-11       Impact factor: 2.736

4.  Spatial and temporal localization of the melanocortin 1 receptor and its ligand α-melanocyte-stimulating hormone during cutaneous wound repair.

Authors:  Lara A Muffley; Kathy Q Zhu; Loren H Engrav; Nicole S Gibran; Anne M Hocking
Journal:  J Histochem Cytochem       Date:  2011-01-12       Impact factor: 2.479

Review 5.  Activins and related proteins in the establishment of pregnancy.

Authors:  Pasquale Florio; Massimo Gabbanini; Lavinia E Borges; Lorella Bonaccorsi; Serena Pinzauti; Fernando M Reis; Paulo Boy Torres; Giuseppe Rago; Pietro Litta; Felice Petraglia
Journal:  Reprod Sci       Date:  2010-04       Impact factor: 3.060

6.  Cutaneous reactions at sites of herpes zoster scars: an expanded spectrum.

Authors:  L Requena; H Kutzner; P Escalonilla; S Ortiz; J Schaller; A Rohwedder
Journal:  Br J Dermatol       Date:  1998-01       Impact factor: 9.302

7.  Effect of recombinant human epidermal growth factor against cutaneous scar formation in murine full-thickness wound healing.

Authors:  Young Seok Kim; Dae Hyun Lew; Kwan Chul Tark; Dong Kyun Rah; Joon Pio Hong
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

8.  Rare sequelae of herpes zoster in HIV positive patient.

Authors:  Sandeep K Goel; Maria Kuruvila
Journal:  Indian J Dermatol Venereol Leprol       Date:  2002 Sep-Oct       Impact factor: 2.545

9.  Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy.

Authors:  Giustino Parruti; Monica Tontodonati; Cristina Rebuzzi; Ennio Polilli; Federica Sozio; Augusta Consorte; Adriana Agostinone; Francesco Di Masi; Gabriele Congedo; Domenico D'Antonio; Carla Granchelli; Claudio D'Amario; Carlo Carunchio; Lucio Pippa; Lamberto Manzoli; Antonio Volpi
Journal:  BMC Med       Date:  2010-10-11       Impact factor: 8.775

  9 in total
  4 in total

Review 1.  [Herpes zoster and postherpetic neuralgia].

Authors:  U Wollina; J Machetanz
Journal:  Hautarzt       Date:  2016-08       Impact factor: 0.751

Review 2.  Variations in herpes zoster manifestation.

Authors:  Uwe Wollina
Journal:  Indian J Med Res       Date:  2017-03       Impact factor: 2.375

3.  Immunocompromised Districts of Skin: A Case Series and a Literature Review.

Authors:  Aleksandra Vojvodic; Michael Tirant; Veronica di Nardo; Torello Lotti; Uwe Wollina
Journal:  Open Access Maced J Med Sci       Date:  2019-09-10

Review 4.  Herpes zoster: A Review of Clinical Manifestations and Management.

Authors:  Anant Patil; Mohamad Goldust; Uwe Wollina
Journal:  Viruses       Date:  2022-01-19       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.